Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The hardest weeks of my life: A qualitative study of experiences, practice changes, and emotional burden of New York City oncology physicians during the COVID-19 surge in 2020
    Journal Article

    Lynch, K. A.; Green, A.; Saltz, L.; Epstein, A. S.; Romano, D. R.; Vera, J.; Nelson, J. E.
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: A phase I first-in-humans study of (89)Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody
    Journal Article

    Farwell, M. D.; Gamache, R. F.; Babazada, H.; Hellmann, M. D.; Harding, J. J.; Korn, R.; Mascioni, A.; Le, W.; Wilson, I.; Gordon, M. S.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): Final analysis of a randomised, open-label, phase 3 study
    Journal Article

    Diaz, L. A. Jr; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
    Journal Article

    Pereira, P. M. R.; Mandleywala, K.; Monette, S.; Lumish, M.; Tully, K. M.; Panikar, S. S.; Cornejo, M.; Mauguen, A.; Ragupathi, A.; Keltee, N. C.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Survival after induction chemotherapy and chemoradiation versus chemoradiation and adjuvant chemotherapy for locally advanced rectal cancer
    Journal Article

    Kim, J. K.; Marco, M. R.; Roxburgh, C. S. D.; Chen, C. T.; Cercek, A.; Strombom, P.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P. B.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study
    Journal Article

    Flory, A.; Kruglyak, K. M.; Tynan, J. A.; McLennan, L. M.; Rafalko, J. M.; Fiaux, P. C.; Hernandez, G. E.; Marass, F.; Nakashe, P.; Ruiz-Perez, C. A.; more...
    PLoS ONE (2022)

    Fulltext@MSK | Save
  • Effect of lanreotide autogel/depot (LAN) on tumor growth rate (TGR) in patients with metastatic bronchopulmonary neuroendocrine tumors (BP-NETs): Exploratory data from the phase 3 SPINET study
    Meeting Abstract

    Baudin, E.; Hörsch, D.; Singh, S.; Caplin, M.; Ferone, D.; Wolin, E.; Capdevila, J.; Buikhuisen, W.; Raderer, M.; Houchard, A.; more...
    Journal of Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • Prognostic factors for progression-free survival (PFS) in patients with metastatic bronchopulmonary neuroendocrine tumors (BP-NETs): Exploratory data from the phase 3 SPINET study
    Meeting Abstract

    Baudin, E.; Hörsch, D.; Singh, S.; Caplin, M.; Ferone, D.; Wolin, E.; Capdevila, J.; Buikhuisen, W.; Raderer, M.; Houchard, A.; more...
    Journal of Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens: Impact of prior irinotecan (IRI) exposure
    Meeting Abstract

    Yu, K. H.; Cockrum, P.; Surinach, A.; Lamarre, N.; Wang, S.; O'Reilly, E. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment
    Meeting Abstract

    Sanchez Vega, F.; Chatila, W. K.; Kim, J. K.; Walch, H. S.; Marco, M.; Chen, C. T.; Wu, F.; Khalil, D.; Ganesh, K.; Qu, X.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save